167 related articles for article (PubMed ID: 26183839)
1. Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.
Berlth F; Mönig S; Pinther B; Grimminger P; Maus M; Schlösser H; Plum P; Warnecke-Eberz U; Harismendy O; Drebber U; Bollschweiler E; Hölscher A; Alakus H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S822-31. PubMed ID: 26183839
[TBL] [Abstract][Full Text] [Related]
2. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.
Schlößer HA; Drebber U; Urbanski A; Haase S; Baltin C; Berlth F; Neiß S; von Bergwelt-Baildon M; Fetzner UK; Warnecke-Eberz U; Bollschweiler E; Hölscher AH; Mönig SP; Alakus H
Gastric Cancer; 2017 Jan; 20(1):83-91. PubMed ID: 26643879
[TBL] [Abstract][Full Text] [Related]
3. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
[TBL] [Abstract][Full Text] [Related]
4. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M
Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622
[TBL] [Abstract][Full Text] [Related]
5. Glucose Transporter-1 (GLUT-1) Expression is Associated with Tumor Size and Poor Prognosis in Locally Advanced Gastric Cancer.
Yin C; Gao B; Yang J; Wu J
Med Sci Monit Basic Res; 2020 Mar; 26():e920778. PubMed ID: 32201432
[TBL] [Abstract][Full Text] [Related]
6. Histological grading in gastric cancer by Ming classification: correlation with histopathological subtypes, metastasis, and prognosis.
Luebke T; Baldus SE; Grass G; Bollschweiler E; Thiele J; Dienes HP; Hoelscher AH; Moenig SP
World J Surg; 2005 Nov; 29(11):1422-7; discussion 1428. PubMed ID: 16222448
[TBL] [Abstract][Full Text] [Related]
7. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
[TBL] [Abstract][Full Text] [Related]
9. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.
Alakus H; Batur M; Schmidt M; Drebber U; Baldus SE; Vallböhmer D; Prenzel KL; Metzger R; Bollschweiler E; Hölscher AH; Mönig SP
Nucl Med Commun; 2010 Jun; 31(6):532-8. PubMed ID: 20220543
[TBL] [Abstract][Full Text] [Related]
10. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
[TBL] [Abstract][Full Text] [Related]
12. [GRP78 expression in gastric cancer and its clinical significance].
Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
[TBL] [Abstract][Full Text] [Related]
13. Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features.
Qiu MZ; Han B; Luo HY; Zhou ZW; Wang ZQ; Wang FH; Li YH; Xu RH
Tumour Biol; 2011 Feb; 32(1):159-66. PubMed ID: 20845004
[TBL] [Abstract][Full Text] [Related]
14. Tumor volume as a prognostic factor was superior to the seventh edition of the pT classification in resectable gastric cancer.
Jiang N; Deng JY; Ding XW; Liu Y; Liang H
Eur J Surg Oncol; 2015 Mar; 41(3):315-22. PubMed ID: 25601610
[TBL] [Abstract][Full Text] [Related]
15. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
[TBL] [Abstract][Full Text] [Related]
16. Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis.
Mönig S; Baldus SE; Collet PH; Zirbes TK; Bollschweiler E; Thiele J; Dienes HP; Hölscher AH
Anticancer Res; 2001; 21(1B):617-20. PubMed ID: 11299815
[TBL] [Abstract][Full Text] [Related]
17. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Nguyen XC; Lee WW; Chung JH; Park SY; Sung SW; Kim YK; So Y; Lee DS; Chung JK; Lee MC; Kim SE
Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
[TBL] [Abstract][Full Text] [Related]
18. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
Hur H; Kim YB; Ham IH; Lee D
J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
[TBL] [Abstract][Full Text] [Related]
19. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the UICC/AJCC 1992 and 1997 pN categories for gastric cancer patients after surgery.
Wu CW; Hsieh MC; Lo SS; Shen KH; Lui WY; P'eng FK
Hepatogastroenterology; 2001; 48(37):279-84. PubMed ID: 11268985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
